Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria

被引：12

作者：

Ho, Soo Yei ^{[1
]}

Wang, Weiling ^{[1
]}

Ng, Fui Mee ^{[1
]}

Wong, Yun Xuan ^{[1
]}

Poh, Zhi Ying ^{[1
]}

Tan, Sum Wai Eldwin ^{[1
]}

Ang, Shi Hua ^{[1
]}

Liew, Si Si ^{[1
]}

Wong, Yin Sze Joyner ^{[1
]}

Tan, Yvonne ^{[1
]}

Poulsen, Anders ^{[1
]}

Pendharkar, Vishal ^{[1
]}

Sangthongpitag, Kanda ^{[1
]}

Manchester, John ^{[2
,3
]}

Basarab, Gregory ^{[2
,4
]}

Hill, Jeffrey ^{[1
]}

Keller, Thomas H. ^{[1
]}

Cherian, Joseph ^{[1
]}

机构：

[1] Expt Therapeut Ctr, 13 Biopolis Way, Nanos 13866, Singapore

[2] AstraZeneca, 35 Gatehouse Dr, Waltham, MA 02451 USA

[3] Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA

[4] Univ Cape Town, Dept Chem, H3D,PD Hahn Bldg,Upper Campus, ZA-7700 Rondebosch, South Africa

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2018年 / 157卷

关键词：

Gram-negative bacteria; Dual target inhibition; Gyrase B; ParE; Gyrase; TopoIV; TOPOISOMERASE-IV PARE; PSEUDOMONAS-AERUGINOSA; DNA; SUBUNIT; AVIBACTAM; SPECTRUM; BROAD; GYRB;

D O I：

10.1016/j.ejmech.2018.08.025

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Even though many GyrB and ParE inhibitors have been reported in the literature, few possess activity against Gram-negative bacteria. This is primarily due to limited permeability across Gram-negative bacterial membrane as well as bacterial efflux mechanisms. Permeability of compounds across Gramnegative bacterial membranes depends on many factors including physicochemical properties of the inhibitors. Herein, we show the optimization of pyridylureas leading to compounds with potent activity against Gram-negative bacterial species such as P.aeruginosa, E.coli and A.baumannii. (C) 2018 Elsevier Masson SAS. All rights reserved.

引用

页码：610 / 621

页数：12

共 50 条

[21] Alternative drugs against multiresistant Gram-negative bacteria
Perdigao Neto, Lauro Vieira
Oliveira, Maura Salaroli
Orsi, Tatiana D'Annibale
Boas do Prado, Gladys Villas
Ruedas Martins, Roberta Cristina
Leite, Gleice Cristina
Marchi, Ana Paula
de Lira, Esther Sant'Ana
Cortes, Marina Farrel
Sanchez Espinoza, Evelyn Patricia
de Maio Carrilho, Claudia Maria Dantas
Boszczowski, Icaro
Guimaraes, Thais
Costa, Silvia Figueiredo
Levin, Anna S.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 23 : 33 - 37
[22] Activity of the Antiseptic Polyhexanide Against Gram-Negative Bacteria
Fabry, Werner Hugo Karl
Kock, Hans-Juergen
Vahlensieck, Winfried
MICROBIAL DRUG RESISTANCE, 2014, 20 (02) : 138 - 143
[23] Chimeric peptidomimetic antibiotics against Gram-negative bacteria
Anatol Luther
Matthias Urfer
Michael Zahn
Maik Müller
Shuang-Yan Wang
Milon Mondal
Alessandra Vitale
Jean-Baptiste Hartmann
Timothy Sharpe
Fabio Lo Monte
Harsha Kocherla
Elizabeth Cline
Gabriella Pessi
Parthasarathi Rath
Seyed Majed Modaresi
Petra Chiquet
Sarah Stiegeler
Carolin Verbree
Tobias Remus
Michel Schmitt
Caroline Kolopp
Marie-Anne Westwood
Nicolas Desjonquères
Emile Brabet
Sophie Hell
Karen LePoupon
Annie Vermeulen
Régis Jaisson
Virginie Rithié
Grégory Upert
Alexander Lederer
Peter Zbinden
Achim Wach
Kerstin Moehle
Katja Zerbe
Hans H. Locher
Francesca Bernardini
Glenn E. Dale
Leo Eberl
Bernd Wollscheid
Sebastian Hiller
John A. Robinson
Daniel Obrecht
Nature, 2019, 576 : 452 - 458
[24] ANTIBACTERIAL ACTIVITY OF PIPERACILLIN AGAINST GRAM-NEGATIVE BACTERIA
GENTRY, LO
IVES, RT
JEMSEK, JG
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1979, 26 (02): : 158 - 164
[25] Streptothricin, a new selective bacteriostatic and bactericidal agent active against gram-negative bacteria
Waksman, SA
Woodruff, HB
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1942, 49 (02): : 207 - 210
[26] Understanding efflux in Gram-negative bacteria: opportunities for drug discovery
Schweizer, Herbert P.
EXPERT OPINION ON DRUG DISCOVERY, 2012, 7 (07) : 633 - 642
[27] Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria
Hernandez, Vincent
Crepin, Thibaut
Palencia, Andres
Cusack, Stephen
Akama, Tsutomu
Baker, Stephen J.
Bu, Wei
Feng, Lisa
Freund, Yvonne R.
Liu, Liang
Meewan, Maliwan
Mohan, Manisha
Mao, Weimin
Rock, Fernando L.
Sexton, Holly
Sheoran, Anita
Zhang, Yanchen
Zhang, Yong-Kang
Zhou, Yasheen
Nieman, James A.
Anugula, Mahipal Reddy
Keramane, El Mehdi
Savariraj, Kingsley
Reddy, D. Shekhar
Sharma, Rashmi
Subedi, Rajendra
Singh, Rajeshwar
O'Leary, Ann
Simon, Nerissa L.
De Marsh, Peter L.
Mushtaq, Shazad
Warner, Marina
Livermore, David M.
Alley, M. R. K.
Plattner, Jacob J.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (03) : 1394 - 1403
[28] Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria
Skepper, Colin K.
Armstrong, Duncan
Balibar, Carl J.
Bauer, Daniel
Bellamacina, Cornelia
Benton, Bret M.
Bussiere, Dirksen
De Pascale, Gianfranco
De Vicente, Javier
Dean, Charles R.
Dhumale, Bhavesh
Fisher, L. Mark
Fuller, John
Fulsunder, Mangesh
Holder, Lauren M.
Hu, Cheng
Kantariya, Bhavin
Lapointe, Guillaume
Leeds, Jennifer A.
Li, Xiaolin
Lu, Peichao
Lvov, Anatoli
Ma, Sylvia
Madhavan, Shravanthi
Malekar, Swapnil
McKenney, David
Mergo, Wosenu
Metzger, Louis
Moser, Heinz E.
Mutnick, Daniel
Noeske, Jonas
Osborne, Colin
Patel, Ashish
Patel, Darshit
Patel, Tushar
Prajapati, Krunal
Prosen, Katherine R.
Reck, Folkert
Richie, Daryl L.
Rico, Alice
Sanderson, Mark R.
Satasia, Shailesh
Sawyer, William S.
Selvarajah, Jogitha
Shah, Nirav
Shanghavi, Kartik
Shu, Wei
Thompson, Katherine, V
Traebert, Martin
Vala, Anand
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (14) : 7773 - 7816
[29] Discovery and Synthesis of a Gram-Negative-Active Cationic Lipopeptide Antibiotic Inspired by Primary Sequences from Underexplored Gram-Negative Bacteria
Sun, Runze
You, Ruixiang
Yu, Xuchang
Zhao, Di
Li, Lei
ORGANIC LETTERS, 2024, 26 (07) : 1348 - 1352
[30] In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria
Giacometti, A
Cirioni, O
Greganti, G
Quarta, M
Scalise, G
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) : 3320 - 3324

← 1 2 3 4 5 →